Debbie Liao
Boundless Bio (United States) · 70 works · 7,866 citations · h-index 17
Top works
- PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
- A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis
- Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle
- Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer
- Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ
- Hypoxia: A key regulator of angiogenesis in cancer
- Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression
- PPARδ is a very low-density lipoprotein sensor in macrophages
- Hypoxia-Inducible Factor-1α Is a Key Regulator of Metastasis in a Transgenic Model of Cancer Initiation and Progression
- Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model
- Tumor-Associated Macrophages Regulate Murine Breast Cancer Stem Cells Through a Novel Paracrine EGFR/Stat3/Sox-2 Signaling Pathway
- Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer
- EGF816 Exerts Anticancer Effects in Non–Small Cell Lung Cancer by Irreversibly and Selectively Targeting Primary and Acquired Activating Mutations in the EGF Receptor
- Endothelial Cell HIF-1α and HIF-2α Differentially Regulate Metastatic Success
- HIF1α is a critical regulator of secretory differentiation and activation, but not vascular expansion, in the mouse mammary gland
- The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression
- Synthetic enzyme inhibitor: a novel targeting ligand for nanotherapeutic drug delivery inhibiting tumor growth without systemic toxicity
- Targeted Therapeutic Remodeling of the Tumor Microenvironment Improves an HER-2 DNA Vaccine and Prevents Recurrence in a Murine Breast Cancer Model
- Abstract 1733: EGF816, a novel covalent inhibitor of mutant-selective epidermal growth factor receptor, overcomes T790M-mediated resistance in NSCLC
- VHL Deletion Impairs Mammary Alveologenesis but Is Not Sufficient for Mammary Tumorigenesis